Medtronic Plc (MDT) Files Form 4 Insider Selling : Hoedt Rob Ten Sells 12,100 Shares

Medtronic Plc (MDT): Hoedt Rob Ten , EVP & President EMEAC of Medtronic Plc sold 12,100 shares on Jun 1, 2016. The Insider selling transaction was reported by the company on Jun 3, 2016 to the Securities and Exchange Commission. The shares were sold at $80.54 per share for a total value of $974,399.56 , the company said in a SEC Form 4 Filing.

Other Insider transactions have been reported by the company according to SEC Form 4, on Apr 5, 2016, Richard Kuntz (SrVP & Chief Scien, Clin, Reg) sold 4,000 shares at $75.22 per share price.On Mar 22, 2016, Shirley A Jackson (director) sold 1,238 shares at $75.60 per share price.Also, On Mar 21, 2016, Omar Ishrak (Chairman & CEO) sold 23,799 shares at $76.51 per share price.On Mar 8, 2016, Bryan C Hanson (EVP, President, MITG) sold 5,000 shares at $75.00 per share price.

Shares of Medtronic PLC (MDT) ended Friday, Jun 3, 2016 session in red amid volatile trading. The shares closed down -0.05 points or -0.06% at $82.94 with 53,43,802 shares getting traded. Post opening the session at $82.99, the shares hit an intraday low of $82.35 and an intraday high of $83.21 and the price vacillated in this range throughout the day. The company has a market cap of $149,379 M and the number of outstanding shares has been calculated to be 1,80,10,43,300 shares. The 52-week high of Medtronic PLC is $83.29 and the 52-week low is $55.54.

Medtronic PLC Money Flow Index Chart

Company has been under the radar of several Street Analysts.Medtronic PLC is Reiterated by Wedbush to Neutral and the brokerage firm has raised the Price Target to $ 82 from a previous price target of $79 .The Rating was issued on Jun 1, 2016.Medtronic PLC is Initiated by Sun Trust Rbsn Humphrey to Buy and the brokerage firm has set the Price Target at $93. The Rating was issued on Apr 25, 2016.Medtronic PLC is Reiterated by Needham to Buy and the brokerage firm has raised the Price Target to $ 90 from a previous price target of $88 .The Rating was issued on Apr 5, 2016.Medtronic PLC is Initiated by Nomura to Buy. The Rating was issued on Mar 17, 2016.

Medtronic plc (Medtronic) is a medical technology and services company. The Company develops manufactures and markets its medical devices and technologies to hospitals physicians clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group Minimally Invasive Technologies Group Restorative Therapies Group and Diabetes Group. The Cardiac and Vascular Group segment includes Cardiac Rhythm & Heart Failure Coronary & Structural Heart and Aortic & Peripheral Vascula. Its Minimally Invasive Technologies Group segment includes Surgical Solutions and Patient Monitoring and Recovery. Its Restorative Therapies Group segment includes Spine Neuromodulation Surgical Technologies and Neurovascular. Its Diabetes Group segment includes Intensive Insulin Management Non-Intensive Diabetes Therapies and Diabetes Services & Solutions. Medtronic Inc. is a subsidiary of the Company.

Leave a Reply

Medtronic PLC - Is it time to Sell?

Top Brokerage Firms are advising their investors on Medtronic PLC. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.